Skip to main content

Table 3 Predictors of progression-free survival

From: I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma

 

Univariate analysis

Multivariate analysis

Hazard ratio

95% CI

P value

Hazard ratio

95% CI

P value

Tumor thrombi

 No

1

  

1

  

 Yes

3.837

1.658–8.878

0.002

4.480

0.922–21.759

0.063

BCLC stage

 A

1

  

1

  

 B

2.186

1.218–3.921

0.009

2.728

1.443–5.158

0.002

 C

5.978

2.207–16.196

 < 0.001

2.437

0.426 –13.958

0.317

Treatment protocols

 Combined

1

  

1

  

 TACE alone

1.884

1.095–3.240

0.022

2.392

1.297–4.413

0.003

  1. AFP Alphafetoprotein, BCLC Barcelona clinic liver cancer, TACE transcatheter arterial chemoembolization
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us